NJ Bio, Inc., is a Contract Research and Development Organization (CRO/CDMO) offering integrated chemistry and biology solutions to biopharmaceutical and chemistry-driven biotechnology companies. We have been recognized for excellence in CRO services for six consecutive years at the Annual World ADC Awards, reflecting our consistent performance and technical depth in the field. Our expertise spans ADC, AOC and PDC design and development including linker-payload chemistry, conjugation technologies, in vitro/ in vivo studies, analytical characterization and early-phase GMP manufacturing. Our expert team provides end-to-end, tailored services to address complex scientific challenges from discovery to IND-enabling, supporting partners to advance novel therapies to the market and achieve improved clinical outcomes.